The Year In Which Comforting American Myths Were Ravaged Authored by James Bovard via The American Institute for Economic Research, Thanks in large part to Covid lockdowns,...
At long last, the annus horribilus 2020 is coming to an end, and it’s time to get our portfolios in order for the new year ahead....
Operation Warp Speed – the Trump administration’s program to accelerate Covid-19 vaccine development and distribution – succeeded on the development component, but is failing in the early stages of distribution.
Pfizer (PFE) & German partner BioNTech (BNTX) have won another order from the European Union to supply an additional 100 million doses of its COVID-19 vaccine...
Regeneron Pharmaceuticals revealed encouraging initial data from its ongoing Phase 1/2/3 clinical trial of its antibody cocktail (casirivimab and imdevimab) in hospitalized COVID-19 patients on low-flow...
Pharmaceutical scientist sees potential problems with remdesivir as a COVID-19 treatment Credit: University of Cincinnati While the world has its eyes on vaccines to stop the...
Moderna reaches an agreement to supply the government of South Korea with 20 million or more doses of its COVID-19 vaccine.
Shares of Hepion Pharmaceuticals exploded 47% in Wednesday’s pre-market trading after the biopharma company released “positive” top line trial results for its oral inhibitor used in...
China's leading local on-demand delivery and retail platform, Dada Group, has been ranked 211th on the Hurun Research Institute's "China's Top 500 Private Enterprises in 2020"...
US Troops In S.Korea First To Receive Mass Vaccination As Host Country Cases Soar The first large-scale Pentagon vaccination effort of US troops stationed abroad is...
The United States Department of Defense (DOD) awarded Moderna a contract valued at $1,966,598,000 for an additional 100 million doses of the company's Covid-19 vaccine.
rBIO launched with technology that can reduce the cost of insulin by 30 percent, making U.S. manufacturing cost-effective for insulin and several other drugs.
As Arcturus Therapeutics charges full speed into a Phase II trial for its single-dose Covid-19 vaccine in Singapore, some analysts say weak Phase I/II data point...
Quanterix announced that the US FDA has provided EUA for its Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test
RBC Capital downgraded Aprea Therapeutics to Hold from Buy as the biopharma company said Monday that its Phase 3 trial of Eprenetapopt molecule in TP53 Mutant...
Novavax announced the initiation of the pivotal Phase 3 study of NVX-CoV2373, its COVID-19 vaccine candidate, in the US and Mexico after delaying the start twice....
Shares of Myovant Sciences surged 20.5% after the biopharma company announced a collaboration with Pfizer (PFE) to jointly develop and commercialize ORGOVYX – a drug for...
California Gov Warns LA Lockdown Likely To Be Extended; Spanish COVID Deaths Top 50K: Live Updates Summary: California Gov extends LA lockdown Spain deaths top 50K...
Spanish COVID Deaths Top 50K; UK's "Mutant" COVID Strain No More Deadly Than Regular Thing: Live Updates Summary: Spain deaths top 50K WHO says UK study...
A vaccine being developed by the Nanovaccine Institute at Iowa State University (ISU) will be able to be administered without needles and in one dose.
UK's Mutant COVID Strain Conquers Scandinavia As Doctors Warn Of "Grim Month Ahead"; Russia Extends UK Travel Ban: Live Updates Summary: Finland latest to confirm presence...
AstraZeneca and MSD’s (Merck (MRK) is known as MSD outside the US and Canada) Lynparza (olaparib) has been approved in Japan for the treatment of three...
United Therapeutics Corporation has announced that it has agreed to buy a Priority Review Voucher (PRV) for $105 million, which it plans to use with an...
Shares of IMV Inc. jumped 13% in Monday’s pre-market trading after the clinical-stage biopharma company announced positive results for its COVID-19 vaccine
AstraZeneca’s COVID-19 vaccine will be effective against the new variant of the virus
Scientists Scramble To Identify Culprit Behind Covid Vaccine Allergic Reactions All is not going according to plan in the global rollout of what is arguably the...
Inovio Pharmaceuticals reported that Phase 1 clinical trial data showed that the COVID-19 vaccine candidate was immunogenic in 100% of the participants and induced neutralizing antibody...
A resurgence of coronavirus cases in several countries and a new COVID-19 variant identified in the UK are boosting fears over a slew of lockdown and...
Take a deep breath, get ready, the New Year is just around the corner, and while we’re all ready to celebrate – just on principle, because...
Reviewing 2019’s key digital health stories last year I suggested that, while big strides continued to be made, The post 5 ways digital health, and digital...